In line with this rationale, in this study, we demonstrated that intratumoral injection of HLA induced extensive tumor necrosis, shaped an inflamed TIME characterized by increased CD8+ T cells and PD-L1 expression, and suppressed tumor growth without causing adverse effects in preclinical TNBC models. The gene discussed is CD8A; the disease is neoplasm.